Abbott has no intention of making any significant changes to the Guidant vascular facilities or employee base. We look forward to welcoming the Guidant vascular and endovascular teams.
None of these are material to this transaction.
We are confident that Abbott will enjoy the full benefits of the acquisition.
We are confident we have freedom to operate. With respect to Guidant's product, it would be inappropriate for us to comment.
We bought this land in anticipation of future growth and expansion. It's premature for Abbott to make any announcement regarding the future development or use of the land.
We forged both of those agreements so that Abbott's vascular business will have some significant growth opportunities in either situation.
We're very interested in acquiring Guidant's vascular business. If this acquisition of Guidant's vascular business were to go through, it would significantly enhance our vascular business.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.